Showing results (161-170 of 204) with videos related to

Sort By:
Pageof 21
Rheumatology (Oxford, England)|September 22, 2018
European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosisGiuseppina Abignano, Jelena Blagojevic, Lesley-Anne Bissell, et al.
Clinical and Experimental Rheumatology|September 3, 2016
The unmet need in rheumatology: reports from the Targeted Therapies meeting 2016Kevin L Winthrop, Vibeke Strand, Désiréé M van der Heijde, et al.
Annals of the Rheumatic Diseases|March 8, 2011
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritisMaya H Buch, Josef S Smolen, Neil Betteridge, et al.
BMC Musculoskeletal Disorders|December 26, 2014
The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drugNuria C Navarro Coy, Sarah Brown, Ailsa Bosworth, et al.
RMD Open|July 20, 2020
Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbiditiesTore K Kvien, Alejandro Balsa, Neil Betteridge, et al.
Journal of Scleroderma and Related Disorders|July 28, 2021
Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomesAlain Lescoat, Susan L Murphy, David Roofeh, et al.
Annals of the Rheumatic Diseases|August 6, 2013
Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)J L Nam, E Villeneuve, E M A Hensor, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 16, 2023
Long-term durability of self-expanding and balloon-expandable transcatheter aortic valve prostheses: UK TAVI registryNoman Ali, David Hildick-Smith, Jessica Parker, et al.
Rheumatology (Oxford, England)|February 24, 2026
A randomised open label pilot trial comparing mycophenolate mofetil with no immunosuppression in limited cutaneous systemic sclerosis (MINIMISE-Pilot)Christopher P Denton, Philip Yee, Medha Kanitkar, et al.
Annals of the Rheumatic Diseases|May 16, 2014
Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatologyMaya H Buch, Lucia Silva-Fernandez, Loreto Carmona, et al.
Pageof 21